Christine Dozier

Christine Dozier

Auto-generated profile, based on publicly available information

Christine Dozier

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Integrative (CBI), Université de Toulouse, CNRS, UPS, 31062 Toulouse, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2017 in Oncogene
Verified
Journal Article
Closed access
CDC Dozier
C Dozier
LML Mazzolini
L Mazzolini
CCC Cénac
C Cénac
CFC Froment
C Froment
OBO Burlet-Schiltz
O Burlet-Schiltz
SMS Manenti
S Manenti

9 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJustine Creff
Justine Creff
ANAda Nowosad
Ada Nowosad
APAnne Prel
Anne Prel
APAnne Pizzoccaro
Anne Pizzoccaro
MAMarion Aguirrebengoa
Marion Aguirrebengoa
ABArnaud Besson
Arnaud Besson
P57 Kip2 is a cyclin/CDK inhibitor and a negative regulator of cell proliferation. Remarkably, p57 is the only CDK inhibitor required for embryonic development and p57 knockout mice display multiple developmental anomalies, including intestinal shortening. Here, we report that p57 regulates intestinal stem cell (ISC) fate and proliferation in a CDK-independent manner during intestinal development. In absence of p57, proliferation in intestinal crypts is markedly increased and genetic labelling experiments revealed an amplification of transit amplifying cells and of Hopx + ISCs, which are no longer quiescent. On the other hand, Lgr5 + crypt-base columnar (CBC) cells were unaffected. RNA-Seq analyses of Hopx + ISCs show major changes in gene expression in absence of p57. We found that p57 binds to and inhibits the activity of Ascl2, a transcription factor critical for ISC specification and maintenance, by participating in the recruitment of a corepressor complex to Ascl2 target gene promoters. Thus, our data suggests that during intestinal development, p57 plays a key role in maintaining Hopx + stem cell quiescence and repressing the ISC phenotype outside of the crypt bottom by inhibiting the transcription factor Ascl2 in a CDK-independent manner.

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LRLeo Rolland
Leo Rolland
EMElodie Mitri
Elodie Mitri
CDChristine Dozier
Christine Dozier
MAMarion Aguirrebengoa
Marion Aguirrebengoa
INIvan Nemazanyy
Ivan Nemazanyy
ABArnaud Besson
Arnaud Besson
The metabolic needs of a cell are tightly linked to its proliferative state and increasing evidence indicate an extensive bidirectional crosstalk between metabolic pathways and cell cycle regulators. In cancer cells, metabolism is reprogrammed to couple energetic needs and relentless proliferation. The cyclin/CDK inhibitor p27 Kip1 (p27) is frequently inactivated in cancers. p27 is also involved in multiple cellular processes, including transcriptional regulation or autophagy induction. Herein, we investigated the effect of p27 loss on cell metabolism. The knockout of p27 in immortalized mouse fibroblasts increases glucose uptake and glycolysis, while decreasing mitochondrial ATP production, consistent with induction of a Warburg effect, and this was accompanied by an increased glutamine dependency to feed the TCA cycle. Our data suggest that p27 loss causes this phenotype through extensive transcriptional remodeling of metabolic gene expression. Importantly, p27 silencing in human retinal RPE1-hTERT cells was sufficient to induce a Warburg effect. Together, these results reveal a new function of p27 in regulating energy metabolism and that loss of p27 expression is sufficient to induce metabolic reprogramming and a Warburg effect, suggesting that p27 inactivation in cancer cells not only results in the loss of cell cycle inhibition but also enables the metabolic rewiring needed for increased proliferation.